1 week ago
Tempsens Instruments IPO Sees Strong Demand Despite Valuation Concerns
Tempsens Instruments is selling shares to the public in an IPO.
The offer opened on 20 August 2026 and closes on 24 August.
The shares are priced between ₹285 and ₹300 each.
The company wants to raise ₹650 crore.
Many investors have already applied, so the IPO is heavily oversubscribed.
Some market observers say the shares may list above the IPO price based on grey-market trading.
Several brokerages recommend the IPO for long-term investors.
However, they warn that the company’s valuation is expensive and its working-capital needs should be watched.
The article gives a ₹270 grey-market premium but also mentions a separate 38% listing-gain estimate, so those figures are not fully consistent.
Tempsens Instruments’ IPO opened on 20 August 2026 and closes on 24 August, with shares priced at ₹285–₹300.
The company aims to raise ₹650 crore, including ₹555 crore through an Offer for Sale and ₹95 crore in fresh shares.
By 11:21 a.m. on day two, the issue was subscribed 10.33 times, led by the NII segment at 21.87 times.
Market observers reported a grey-market premium of ₹270, while the article separately described the expected listing gain as 38%.
Several brokerages recommended subscribing, citing growth and market position, though they also flagged premium valuation and working-capital intensity.
- Who
- Tempsens Instruments (India) Ltd., investors, market observers, and brokerages covering the IPO.
- What
- Tempsens Instruments is conducting a ₹650 crore initial public offering with a price band of ₹285–₹300 per share.
- Where
- The shares are being offered in the Indian public market, with demand also indicated through the grey market.
- When
- The IPO opened on 20 August 2026 and is scheduled to close on 24 August 2026. The likely allotment date is 25 August and the likely listing date is 28 August 2026.
- Why
- The company is raising funds through ₹95 crore of fresh shares, while ₹555 crore will be offered by existing shareholders through an Offer for Sale.
Reasons to Consider Applying
Reasons for Caution
Growth and market position
Reasons to Consider Applying
Brokerages said the company has strong revenue growth, a diversified product portfolio, international expansion, niche positioning, technical capabilities, and a leading market position.
Reasons for Caution
The article does not identify a direct business challenge to these claims, but notes that the investment case depends on continued growth and the company’s competitive advantages.
Valuation
Reasons to Consider Applying
KC Securities said the premium valuation may be justified by the company’s superior growth, niche positioning, and segment leadership. Several brokerages recommended subscribing for listing gains and long-term potential.
Reasons for Caution
Anand Rathi said the IPO appears fully priced at the upper band, while KC Securities described the valuation as a premium. Anand Rathi cited an implied FY26 P/E of 35.4 times and EV/EBITDA of 25.64 times; KC Securities cited a FY26 P/E of 37.3 times.
Short-term listing prospects
Reasons to Consider Applying
The ₹270 grey-market premium was presented as a sign of strong listing potential, and the article said the IPO could offer a listing gain.
Reasons for Caution
The article’s figures are inconsistent: a ₹270 premium over the ₹300 upper price band implies a much higher percentage premium than the separately stated 38% listing-gain estimate. Grey-market indications are not guaranteed listing prices.
Key facts
- Issue size
- ₹650 crore
- Price band
- ₹285–₹300 per share
- Offer structure
- ₹555 crore Offer for Sale and ₹95 crore fresh issue
- Subscription status
- 10.33 times overall by 11:21 a.m. on day two
- Grey-market premium
- ₹270, according to market observers
- IPO period
- 20–24 August 2026
- Likely dates
- Allotment on 25 August 2026 and listing on 28 August 2026, according to the article
Quotes
KC Securities
Securities firm that assessed the IPO’s valuation and investment prospects.
“At the upper price band of ₹300, the issue is valued at 37.3x FY26 P/E, which is at a premium but can be justified by its superior growth, niche positioning and leadership in the segment.”
livemint.com
“Given its strong revenue growth, diversified product portfolio and expanding international presence, the company may command a valuation premium.”
livemint.com
Sources
Related news
Tempsens Instruments IPO Closes With 184x Subscription, GMP Near 97%
Tempsens Instruments IPO Draws Strong GMP Amid Valuation Concerns
Tempsens Instruments Shares Debut With 110% Premium, Then Slip
Tempsens Instruments IPO Set for Debut as GMP Soars
Tempsens Instruments Sets ₹650-Crore IPO for August 20
Tempsens Instruments IPO: ₹300 Band, ₹313 GMP, Dates Explained
Indian Gen Z Shifts From Study Abroad To Global Courses
Indian Firms Invest $40 Billion in U.S., Supporting Jobs
BPCL, CSE Partner on Biofuels and Circular Economy
India’s Record Wheat Harvest Opens $1.5 Billion Export Window
Nepal Thanks India as Glacial Disaster Rescue Efforts Continue
